Pharmalot Ed Silverman STAT Plus: Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’
Pharmalot Ed Silverman STAT Plus: Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’
Pharmalot Ed Silverman STAT Plus: Pharmalot, Pharmalittle: Brexit, schmexit. Glaxo invests $360 million in the UK
Pharmalot Ed Silverman STAT Plus: FDA sends stern warning to Glaxo over contamination at a penicillin plant
Pharmalot Ed Silverman STAT Plus: Former Glaxo scientists and the feds fight over reviewing allegedly stolen documents
Pharmalot Ed Silverman STAT Plus: Most scientists believe there is a ‘crisis’ reproducing experiments
Pharmalot Ed Silverman STAT Plus: Pharmalot, Pharmalittle: Feds probe Sun Pharma over generic pricing
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries
Pharmalot Ed Silverman Why, in the age of Martin Shkreli, patients are still happy with pharma companies
Pharmalot Ed Silverman STAT Plus: Pharmalot, Pharmalittle: Indian drug makers pursuing acquisitions, Mass. AG looking into Gilead